Chemical Structure : INCB3284 bismesylate
货号: PC-20531Not For Human Use, Lab Use Only.
INCB3284 bismesylate (INCB 3284, INCB003284) is a potent, selective and orally bioavailable hCCR2 antagonist with IC50 of 3.7 nM in antagonism of MCP-1 binding to hCCR2 and 4.7 nM in antagonism of chemotaxis activity.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
INCB3284 bismesylate (INCB 3284, INCB003284) is a potent, selective and orally bioavailable hCCR2 antagonist with IC50 of 3.7 nM in antagonism of MCP-1 binding to hCCR2 and 4.7 nM in antagonism of chemotaxis activity.
INCB3284 potently inhibited CCR2-mediated signaling events such as intracellular calcium mobilization and ERK phosphorylation with IC50 values of 6 and 2.6 nM, respectively.
INCB3284 showed no significant inhibitory activity at a concentration of 1 μM against a panel of >50 ion channels, transporters, chemokine receptors including CCR1, CCR3, CCR5, CXCR3, and CXCR5, and additional GPCRs.
INCB3284 abolished the high salt (HS)-induced increase in BP in KL(+/-) mice, also attenuated the increased renal expressions of serum glucocorticoid-regulated kinase 1, thiazide-sensitive NaCl cotransporter, and ATP synthase β along with the renal structural damage and functional impairment induced by HS loading.
分子量 | 712.75 | |
分子式 | C28H39F3N4O10S2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Xue CB, et al. ACS Med Chem Lett. 2011 Mar 31;2(6):450-4.
2. Saika F, et al. Neurosci Lett. 2018 Feb 5;665:33-37.
3. Zhou X, et al. J Am Soc Nephrol. 2015 Jan;26(1):121-32.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright